Engineered Lipid Excellence – Made in Germany

2021-03-19T10:02:49+01:001. March 2021|Pharma|

Hardly any other area today is as highly regulated by the legislature as the pharmaceutical industry. However, there are currently no manufacturing guidelines for lipid-based excipients, although most drugs consist for the largest part (75 to 99%) of excipients. The team of the Pharma Business Unit at IOI Oleo GmbH is aware of its responsibility as a globally known provider of oleochemical specialties for pharmaceuticals. We were the first company to receive a GMP certificate for our excipients, although this is only required for active ingredients.

Our somewhat different hard fat

2021-01-20T12:08:45+01:007. January 2021|Pharma|

"The hard fat with a difference?" - SOFTISAN® 378 of the IOI Oleo GmbH corresponds to the properties of hard fat according to the official monograph. In this blog post you will experience what is actually hidden behind the product and what its special properties are.

Startoff for the Pharma Team

2020-10-19T09:50:59+02:0025. September 2020|Pharma|

We got off to a running start in preparing for the CPhI Worldwide and intended to proudly present our new Corporate Design there, together with our completely revised catalogues. But, as everyone knows, all trade fairs were cancelled; we are therefore using this medium to bring you closer to our new look and feel.

MIGLYOL® and IMWITOR® as benchmarks in veterinary formulations

2020-09-22T13:19:44+02:002. September 2020|Pharma|

The health situation of companion and farm animals worldwide has developed and improved significantly in recent years. That is very largely due, on the one hand, to pharmaceutical products as well as biological and medically prescribed nutritional supplements and, on the other hand, to the raw materials used. And here too IOI Oleo GmbH’s “Pharma” business unit with its specialties has a role to play.

Strong brands for current trends – cannabidiol

2020-08-24T11:22:40+02:0013. August 2020|Pharma|

The growing acceptance among customers and patients encourages market researchers to forecast outstanding growth potential for cannabidiol (CBD) and cannabis-based products. We have investigated intensively with this topic and wanted to find out which oil is best using acknowledged and objective methods.

Go to Top